system by angiotensin converting enzyme (ACE) inhibitors has proven to be the most effective strategy to Background. Dietary sodium restriction enhances the antiproteinuric and blood pressure lowering effect of lower both blood pressure and proteinuria in proteinuric patients [4] . Unfortunately, the response to ACE inhibition. In clinical practice, however, longterm compliance to a low-sodium diet may be difficult ACE inhibition is blunted by a liberal sodium intake.
Introduction
was withdrawn at least 4 weeks before the start of the study. The study consisted of three 4-week ambulatory periods: a zide (50 mg once daily) was added. At the end of each period adequate but moderate dietary compliance. During the patients visited our out-patient clinic for blood pressure high-sodium and subsequent hydrochlorothiazide measurements and blood sampling. Before each visit patients period urinary sodium excretion amounted to 178 collected three consecutive 24 h urine samples for determina-(158-212) and 180 (156-208) mmol/day, respectively. tion of the urinary excretion of protein, sodium, creatinine Urinary urea excretion did not change significantly and urea. during the study with values of 338 (286-383), 329
To exclude a possible time-dependent effect, we also ana-(287-408) and 360 (307-439) mmol/day, respectively, lysed data obtained during a regular out-patient clinic visit reflecting a stable protein intake. During the low-3 months after the end of this non-randomized study. All sodium period proteinuria was 3.1 (0.7-5.2) g/day and data were obtained in the same way as during the study, except for the fact that patients collected only one 24-h MAP was 89 (83-96) mmHg. High sodium intake urine sample.
resulted in an increase in proteinuria and blood presBlood pressure was measured after 10 min supine rest at sure in six out of seven patients, resulting in a median 1 min intervals during 5 min using an automated device proteinuria of 4.5 (1.6-9.2) g/day (P<0.05 vs low (DinamapB) Figure 1 ).To Serum and urinary electrolytes, urea and creatinine were correct for possible changes in glomerular filtration we determined using an automated multi-analyser (SMA-C, calculated the fractional clearance of protein. During TechniconB). The mean of three measurements was used for the low-salt period the fractional protein filtration was data analysis.
23 (8-44)×10−3 mg/ml, during the high-sodium Results are expressed as median and 95% confidence period 53 (18-86)×10−3 mg/ml (P<0.01 vs low intervals (95% CI ). Statistical analysis was performed using sodium), and after the addition of hydrochlorothiazide the Wilcoxon rank-sign test for paired, non-parametric data.
28 (11-51)×10−3 mg/ml (P<0.05 vs high sodium).
Statistical significance was assumed at 5% level.
Bodyweight was 82.2 (71.1-88.6) kg during the lowsodium period and 82.6 (71.9-89.1) kg during the high-sodium period. The addition of hydrochlorothiaz-
Results
ide resulted in a slight but significant decrease in bodyweight to 82.1 (70.8-88.3) kg (P<0.01). We included seven patients during chronic ACE inhibCreatinine clearance was 75 (43-96) ml/min during the itor treatment (mean duration 33 months) and chronic low-sodium period, 80 (45-104) ml/min during the dietary advice of 50 mmol sodium per day ( Table 1) .
high-sodium period, and tended to be slightly lower In all patients ACE inhibition had lowered proteinuria, with a median value of 61 (41-94) ml/min after the from a median of 7.3 (3.8-9.0) g/day before the onset addition of hydrochlorothiazide (n.s.). The slight of treatment to 2.9 (1.4-5. the three periods, respectively, did not reach statistical Urinary sodium excretion was 100 (67-111) mmol/ day during the low-sodium period, indicating an significance in this small group of patients. None of the patients developed oedema or gout during the reliable estimate of the contribution of the lowering of blood pressure to the antiproteinuric efficacy found in study.
Three months after the end of the study patients the present study. In previous studies performed with agents such as betablockers and calcium channel antagvisited the out-patient clinic. At this time patients used the same medication as before start of the study. onists a blood pressure lowering response of~12% has been shown to correspond to a reduction in Proteinuria was 3.3 (1.2-4.8) g/day and MAP 88 (83-96) mmHg. The fractional protein filtration was proteinuria of~15% [10] . In the present study, the addition of hydrochlorothiazide resulted in a reduction 25 (7-55)×10−3 mg/ml, urinary sodium excretion 107 (68-155) mmol/l, the creatinine clearance was 73 in blood pressure of 10% whereas the reduction in proteinuria was almost 40%. This finding suggests that (44-101) ml/min. None of these parameters were significantly different from data obtained before the start the antiproteinuric effect found after the addition of hydrochlorothiazide to an ACE inhibitor cannot be of the study.
explained solely by blood pressure lowering. The use of diuretics is associated with a number of Discussion metabolic side-effects. In this small study the changes in biochemical parameters during the addition of hydrochlorothiazide did not reach statistical significThe present study confirms that in patients on chronic ance. To assess whether such changes have clinical ACE inhibitor treatment, the antiproteinuric and blood relevance larger and more long-term studies would be pressure lowering effect of ACE inhibition is blunted required. Recent studies support the notion that not by or even lost during a high sodium intake [5, 6, 9] . In only lowering blood pressure, but also reduction of clinical practice, co-treatment with diuretics is often proteinuria per se is important to improve long-term recommended to enhance the antihypertensive effects renal prognosis in proteinuric patients [2, [11] [12] [13] [14] . Thus of ACE inhibition, but the additive effects of diuretics any effort should be made to ensure an optimal theraand ACE inhibition had not been demonstrated in peutic response. Earlier studies have revealed that an proteinuric patients. Interestingly, in the present study optimal response can be achieved by dietary sodium we found that during high sodium intake the antiprorestriction, but long-term compliance is often difficult teinuric as well as the blood pressure response to ACE to obtain. Another possibility for improving antiproinhibition is restored by co-treatment with hydrochlorteinuric efficacy, currently under study, is the combinaothiazide. The improvement in the blood pressure tion of ACE inhibitors and AT-1 receptor antagonists. response during hydrochlorothiazide may have con-
In conclusion, the addition of hydrochlorothiazide tributed to the reduction in proteinuria. However, our restores the responses of proteinuria and blood presstudy was not designed to unravel the mechanism of sure to chronic ACE inhibition in proteinuric patients the antiproteinuric effect, but merely to investigate in whom the therapeutic response has been blunted by whether the effects of dietary non-compliance could be a high sodium intake. These findings, albeit in a small overcome by the addition of hydrochlorothiazide. We group of patients, provide an outlook on more effective did not investigate the effect of another blood pressure lowering agent on proteinuria, so we cannot provide a reduction of proteinuria and also blood pressure as
